Free Trial
NASDAQ:SNYR

Synergy CHC Q1 2026 Earnings Results & Report

Synergy CHC logo
$0.09 0.00 (0.00%)
As of 09/18/2026

Synergy CHC missed analyst earnings expectations in its Q1 2026 results, released May 14, 2026. The company reported EPS of -$0.23 versus the $0.03 consensus estimate, while revenue was $5.49 million.

Earnings Announcement Details

Quarter
Q1 2026
Report Date
Time
Before Market Opens
Conference Call
8:00 AM ET

Synergy CHC EPS Results

Actual EPS
-$0.23
Consensus EPS
$0.03
Beat/Miss
Missed by -$0.26
One Year Ago EPS
N/A
EPS Beat Rate
2 of last 5 quarters

Synergy CHC Revenue Results

Actual Revenue
$5.49 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Synergy CHC Q1 2026 Earnings FAQ

Synergy CHC (NASDAQ:SNYR) reported earnings of -$0.23 per share for Q1 2026, missing the consensus estimate of $0.03. The report was announced on Thursday, May 14, 2026.

Synergy CHC reported revenue of $5.49 million for Q1 2026.

Synergy CHC Earnings Headlines

Synergy CHC Faces Nasdaq Delisting Amid Chapter 11
Here’s Why Trump Won’t End The Iran War
Trump has called an Iran deal close 38 times since the war began, yet the fighting keeps flaring back up. One day it's a ceasefire, the next it's bombs again. The back and forth may be masking a bigger story most investors are missing. See the real reason this conflict may never fully end.tc pixel
See More Synergy CHC Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Synergy CHC? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Synergy CHC and other key companies, straight to your email.

About Synergy CHC

Synergy CHC (NASDAQ:SNYR) is a consumer health and wellness company that develops, markets and distributes dietary supplements and other health-focused consumer products. Its product categories have included cognitive health, sleep support, digestive health, nutritional supplementation and general wellness.

The company’s portfolio has included the FOCUSfactor brand, which is marketed as a nutritional supplement supporting brain health and mental performance. Synergy CHC has also offered products through direct-to-consumer e-commerce channels and third-party online marketplaces, with additional distribution through retail and other commercial channels.

Synergy CHC has operated as a branded consumer health company, emphasizing product development, marketing and distribution rather than providing traditional medical services. Publicly available information about its current leadership, geographic reach and broader operating history is limited.

View Synergy CHC Profile